Caught early, prostate cancer has a 98% survival rate. Treated by experience, the outcomes get better still.
Prostate cancer is the most diagnosed cancer in American men. Most cases are slow-growing and curable when caught early. The decisions that matter most — when to treat, when to monitor, and which treatment is appropriate — depend on getting the diagnosis right and choosing a surgeon whose volume backs up the recommendation.
How we diagnose prostate cancer
PSA screening with attention to PSA velocity and density — not just a single number. Digital rectal exam where indicated. Multiparametric MRI before biopsy when the PSA pattern suggests it, so suspicious areas can be targeted.
When biopsy is required, the transperineal approach lowers infection risk compared to the older transrectal route. Pathology dictates treatment, but the path to clean pathology starts with imaging-targeted sampling.
Treatment matched to the disease
Active surveillance for low-risk disease. Surgical pathology with robotic prostatectomy is the right choice for many men with intermediate- and high-risk disease. External-beam radiation, brachytherapy, and focal therapy each have a place. We say so when one option is better than the others, and we coordinate with radiation oncology when that is the right call.
The first robotic prostatectomy performed in New Jersey was performed by Dr. Savatta in December 2004. Over 3,000 have followed. Volume matters in this operation — for continence outcomes, for nerve preservation, and for cancer control.
Why specialist experience matters
Robotic prostatectomy is technically demanding. Published outcomes correlate with surgeon volume, particularly for continence recovery and erectile function preservation. The decision is who, not just what.
Common questions
What's the right age to start screening?
USPSTF and AUA support shared decision-making starting at age 50, and earlier (45) for higher-risk men, including Black men and those with family history. We discuss your specific risk before ordering labs.
Why MRI before biopsy?
Multiparametric MRI lets us target suspicious lesions instead of taking blind samples. It improves cancer detection and reduces unnecessary biopsies.
Is robotic prostatectomy always the best option?
No. Surgery, radiation, and active surveillance each have a role. We tell you when one approach is genuinely better and we coordinate with radiation oncology when that's the right call.
Sources